VAERS reports by lot

Merck HPV lot J012212: VAERS reports

58 VAERS reports list lot J012212 as a Merck HPV vaccine, received between 2013-11-27 and 2017-01-09. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
58
Reports
29%
Marked serious
0
With a death outcome
22
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological4226%
Gastrointestinal2616%
General / Systemic (non-local)2113%
Cardiac / Cardiovascular1610%
Injection-site / Local reaction149%
Musculoskeletal117%
Allergic / Anaphylactic85%
Dermatological (non-injection-site)85%
Respiratory42%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated32%
Reproductive / Menstrual32%

Where reports came from

U.S. state of the reporter, where given (top 12).

Maryland6
California5
Georgia4
Pennsylvania2
Texas2
Ohio2
Virginia2
North Carolina2
Florida2
New Jersey2
Illinois2
Massachusetts1

Reports by month received

2013-111
2013-122
2014-018
2014-027
2014-034
2014-044
2014-055
2014-062
2014-0710
2014-082
2014-101
2014-111
2015-031
2015-041
2015-061
2015-082
2015-091
2015-111
2016-021
2016-081
2016-091
2017-011

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.